Childhood Cancer

You are here

Home » Grants » All grants tagged with "Solid and Bone Cancers"

All grants tagged with "Solid and Bone Cancers"

Elucidating the role of 5-hydroxymethylcitosine for the function of Polycomb Repressive Complex 2
Josie Majowka
University of Chicago
POST Program Grants, Awarded 2024
Targeting RNA splicing machinery to enhance anti-tumor immunity in neuroblastoma
Karen Yamada
University of California San Francisco
POST Program Grants, Awarded 2024
Defining the role of ALCAM in immune evasion in neuroblastoma
Jakob Schulman
Children’s Hospital of Philadelphia
POST Program Grants, Awarded 2024
Investigating the effects of PAK4 as therapeutic targets for Ewing Sarcoma
Megan Noh
Emory University
POST Program Grants, Awarded 2024
Validating multifunctional extracellular vesicle magbeads as liquid biopsies for pediatric sarcomas
Yusef Mathkour
University of California, Los Angeles
POST Program Grants, Awarded 2024
Targeting mitochondrial adaptive response in pediatric bone sarcomas
Ellie Tiliakou
BC Cancer (Provincial Health Services Authority)
POST Program Grants, Awarded 2024
Investigating the effects of targeted chimeric antigen receptor natural killer cells armored with tumor-attracting chemokine receptors combined with a novel immunomodulator in the treatment of osteosarcoma
Alexandra Sobocinski
New York Medical College
POST Program Grants, Awarded 2024
Targeting chromatin remodeling complex controlled fusion protein function in rhabdosarcoma
Sunwoo Lee
Dana-Farber Cancer Institute
POST Program Grants, Awarded 2024
cGAS-STING regulation and function in neuroblastoma
Abigail Stellrecht
Children’s Hospital of Philadelphia
POST Program Grants, Awarded 2024
Identification of phenotypic effects of genomic changes in retinoblastoma tumors using an aqueous humor liquid biopsy
Nerea Goni
Children’s Hospital Los Angeles
POST Program Grants, Awarded 2024

Pages

All childhood cancer types

Featured Hero

Ailani Myers

Ailani's family calls her a true Warrior Princess as she fights acute lymphoblastic leukemia. Doctors discovered Ailani harbored a rare genetic mutation which makes standard treatment ineffective. Today, Ailani has reached remission!
Read more »